Hims & hers health, inc. (hims) – lawmakers urge crackdown on illegal weight loss drugs, novo's termination of collaboration with hims triggers securities class actions – hagens berman

San francisco, aug. 01, 2025 (globe newswire) -- on july 25, 2025, investors in hims & hers health, inc. (nyse: hims) saw the price of their shares significantly fall during intraday trading on reports that u.s. lawmakers urged the fda to act against copycat versions of weight loss drugs, citing safety concerns.
HIMS Ratings Summary
HIMS Quant Ranking